Michalina Krych1, Elżbieta Katarzyna Biernacka2, Joanna Ponińska3, Piotr Kukla4, Artur Filipecki5, Robert Gajda6, Can Hasdemir7, Charles Antzelevitch8, Agnieszka Kosiec3, Małgorzata Szperl3, Rafał Płoski9, Maria Trusz-Gluza5, Katarzyna Mizia-Stec5, Piotr Hoffman2. 1. Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland. Electronic address: krych.michalina@gmail.com. 2. Department of Congenital Cardiac Defects, Institute of Cardiology, Warsaw, Poland. 3. Department of Molecular Biology, Institute of Cardiology, Warsaw, Poland. 4. Department of Cardiology and Internal Medicine, Specialistic Hospital, Gorlice, Poland. 5. First Department of Cardiology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland. 6. Medical Centre Gajda-Med, Pułtusk, Poland. 7. Department of Cardiology, Ege University School of Medicine, Izmir, Turkey. 8. Lankenau Institute for Medical Research, Wynnewood, PA, USA. 9. Department of Medical Genetics, Warsaw Medical University, Poland.
Abstract
BACKGROUND: Andersen-Tawil syndrome (ATS) is rare channelopathy caused by KCNJ2 mutation and probably KCNJ5. It is characterized by arrhythmias, neurological symptoms, and dysmorphic features. The present study retrospectively examined the characteristics of 11 unrelated families with ATS. METHODS: This study consisted of 11 probands positive for KCNJ2 variants and 33 family members (mean age 30.0±17.3 years, female n=31). Additional genetic screening of 3 LQTS genes (KCNQ1, KCNH2, SCN5A) was performed in 9 families. Predictors of arrhythmias [premature ventricular beats>2000/24h, biventricular and polymorphic ventricular tachycardia (VT)], syncope, and/or cardiac arrest (CA) were evaluated. RESULTS: In KCNJ2 mutation carriers vs non-carriers (n=25 vs n=19) significant differences were observed in U-wave manifestations in V2-V4, Tpeak-Tend duration, QTUc duration (p<0.0001), dysmorphic features, and neurological symptoms. Compared to asymptomatic carriers (n=9), in those with arrhythmias and/or syncope and/or CA (n=16) micrognathia (p=0.004), periodic paralysis (p=0.019), palpitation (p=0.005), U-wave n V2-V4 (p=0.049) were more frequent; QTU (p=0.045) and Tpeak-Tend (p=0.014) were also longer (n=9). In the subgroup of carriers with syncope and/or cardiac arrest (n=10, 90% women), K897T-KCNH2 polymorphism (p=0.02), periodic paralysis (p=0.004), muscle weakness (p=0.04), palpitations (p=0.04), arrhythmias (biventricular VT, p=0.003; polymorphic VT, p=0.009) were observed more frequently. Tpeak-Tend duration was longer (p=0.007) and the percentage of patients with premature ventricular contraction >2000/24h was higher (p=0.005). CONCLUSION: A higher risk of arrhythmia, syncope, and/or CA is associated with the presence of micrognathia, periodic paralysis, and prolonged Tpeak-Tend time. Our findings suggest that K897T may contribute to the occurrence of syncope.
BACKGROUND: Andersen-Tawil syndrome (ATS) is rare channelopathy caused by KCNJ2 mutation and probably KCNJ5. It is characterized by arrhythmias, neurological symptoms, and dysmorphic features. The present study retrospectively examined the characteristics of 11 unrelated families with ATS. METHODS: This study consisted of 11 probands positive for KCNJ2 variants and 33 family members (mean age 30.0±17.3 years, female n=31). Additional genetic screening of 3 LQTS genes (KCNQ1, KCNH2, SCN5A) was performed in 9 families. Predictors of arrhythmias [premature ventricular beats>2000/24h, biventricular and polymorphic ventricular tachycardia (VT)], syncope, and/or cardiac arrest (CA) were evaluated. RESULTS: In KCNJ2 mutation carriers vs non-carriers (n=25 vs n=19) significant differences were observed in U-wave manifestations in V2-V4, Tpeak-Tend duration, QTUc duration (p<0.0001), dysmorphic features, and neurological symptoms. Compared to asymptomatic carriers (n=9), in those with arrhythmias and/or syncope and/or CA (n=16) micrognathia (p=0.004), periodic paralysis (p=0.019), palpitation (p=0.005), U-wave n V2-V4 (p=0.049) were more frequent; QTU (p=0.045) and Tpeak-Tend (p=0.014) were also longer (n=9). In the subgroup of carriers with syncope and/or cardiac arrest (n=10, 90% women), K897T-KCNH2 polymorphism (p=0.02), periodic paralysis (p=0.004), muscle weakness (p=0.04), palpitations (p=0.04), arrhythmias (biventricular VT, p=0.003; polymorphic VT, p=0.009) were observed more frequently. Tpeak-Tend duration was longer (p=0.007) and the percentage of patients with premature ventricular contraction >2000/24h was higher (p=0.005). CONCLUSION: A higher risk of arrhythmia, syncope, and/or CA is associated with the presence of micrognathia, periodic paralysis, and prolonged Tpeak-Tend time. Our findings suggest that K897T may contribute to the occurrence of syncope.
Authors: Ethan Levine; Spencer Z Rosero; Adam S Budzikowski; Arthur J Moss; Wojciech Zareba; James P Daubert Journal: Cleve Clin J Med Date: 2008-08 Impact factor: 2.321
Authors: Michalina Jagodzińska; Małgorzata Szperl; Joanna Ponińska; Agnieszka Kosiec; Robert Gajda; Piotr Kukla; Elżbieta Katarzyna Biernacka Journal: Ann Noninvasive Electrocardiol Date: 2015-06-24 Impact factor: 1.468
Authors: N M Plaster; R Tawil; M Tristani-Firouzi; S Canún; S Bendahhou; A Tsunoda; M R Donaldson; S T Iannaccone; E Brunt; R Barohn; J Clark; F Deymeer; A L George; F A Fish; A Hahn; A Nitu; C Ozdemir; P Serdaroglu; S H Subramony; G Wolfe; Y H Fu; L J Ptácek Journal: Cell Date: 2001-05-18 Impact factor: 41.582
Authors: Li Zhang; D Woodrow Benson; Martin Tristani-Firouzi; Louis J Ptacek; Rabi Tawil; Peter J Schwartz; Alfred L George; Minoru Horie; Gregor Andelfinger; Gregory L Snow; Ying-Hui Fu; Michael J Ackerman; G Michael Vincent Journal: Circulation Date: 2005-05-23 Impact factor: 29.690
Authors: Elena Zaklyazminskaya; Margarita Polyak; Anna Shestak; Mariam Sadekova; Vera Komoliatova; Irina Kiseleva; Leonid Makarov; Dmitriy Podolyak; Grigory Glukhov; Han Zhang; Denis Abramochkin; Olga S Sokolova Journal: Genes (Basel) Date: 2022-03-22 Impact factor: 4.141
Authors: Robert Gajda; Beat Knechtle; Anita Gębska-Kuczerowska; Jacek Gajda; Sebastian Stec; Michalina Krych; Magdalena Kwaśniewska; Wojciech Drygas Journal: Int J Environ Res Public Health Date: 2022-08-19 Impact factor: 4.614